Trial Profile
Safety of an ACE-I/CCB fixed combination (Lercanidipine/Enalapril) in elderly hypertensive patients not adequately controlled by CCB monotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Lercanidipine/enalapril (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Registrational; Therapeutic Use
- 03 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 21 Jun 2011 New trial record